Search | WHO COVID-19 Research Database

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Show: 20 | 50 | 100

Results 1 - 14 de 14

Filter

Therapeutic Vaccination Is the Most Promising Intervention for Long COVID.

Manu, Peter.

Am J Ther ; 30(4): e372-e373, 2023.

Article in English | MEDLINE | ID: covidwho-20239233

Subject(s)

COVID-19 , Post-Acute COVID-19 Syndrome , Humans , COVID-19/prevention & control

Therapeutic Messianism: Belladonna for Heroin Withdrawal, Ivermectin for COVID-19 Infection.

Manu, Peter.

Am J Ther ; 30(3): e257-e258, 2023 05 01.

Article in English | MEDLINE | ID: covidwho-20239232

Subject(s)

Atropa belladonna , COVID-19 , Heroin Dependence , Substance Withdrawal Syndrome , Humans , Heroin , Ivermectin/therapeutic use , Heroin Dependence/drug therapy

Fatal Myocarditis After COVID-19 Vaccination: Fourteen Autopsy-Confirmed Cases.

Manu, Peter.

Am J Ther ; 30(3): e259-e260, 2023 05 01.

Article in English | MEDLINE | ID: covidwho-20239231

Subject(s)

COVID-19 , Myocarditis , Humans , COVID-19 Vaccines/adverse effects , Autopsy , Myocarditis/diagnosis , Myocarditis/etiology , COVID-19/prevention & control , Vaccination

Ivermectin and the Emergence of Long COVID.

Manu, Peter.

Am J Ther ; 30(2): e145, 2023.

Article in English | MEDLINE | ID: covidwho-2243083

Subject(s)

COVID-19 , Ivermectin , Humans , Ivermectin/therapeutic use , Post-Acute COVID-19 Syndrome

Ivermectin for COVID-19: The 2022 Update.

Manu, Peter.

Am J Ther ; 29(6): e647-e648, 2022.

Article in English | MEDLINE | ID: covidwho-2135752

Subject(s)

COVID-19 , Ivermectin , Humans , Ivermectin/therapeutic use

Same-Day Deaths After COVID-19 Vaccinations: Autopsy Findings in 54 Cases.

Manu, Peter.

Am J Ther ; 29(6): e644-e646, 2022.

Article in English | MEDLINE | ID: covidwho-2123139

Subject(s)

COVID-19 Vaccines , COVID-19 , Humans , Autopsy , Cause of Death , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , SARS-CoV-2

Aromatherapy and Fermented Fruits for Long COVID: Placebo-Controlled Placebo Trials?

Manu, Peter.

Am J Ther ; 29(6): e649-e650, 2022.

Article in English | MEDLINE | ID: covidwho-2123138

Subject(s)

Aromatherapy , COVID-19 , Humans , Post-Acute COVID-19 Syndrome , Fruit , Plant Oils

Liraglutide as First-Line Therapy for Type 2 Diabetics With Post-COVID-19 Fatigue Syndrome and Executive Function Deficits.

Manu, Peter.

Am J Ther ; 29(5): e568-e569, 2022.

Article in English | MEDLINE | ID: covidwho-2018324

Subject(s)

COVID-19 Drug Treatment , COVID-19 , Diabetes Mellitus, Type 2 , COVID-19/complications , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Executive Function , Fatigue , Humans , Liraglutide/therapeutic use

Drug Therapy for Unexplained Dyspnea in Post-COVID-19 Fatigue Syndrome: Empagliflozin and Sildenafil.

Manu, Peter.

Am J Ther ; 29(4): e447-e448, 2022 07 01.

Article in English | MEDLINE | ID: covidwho-1784418

Subject(s)

COVID-19 , Benzhydryl Compounds , COVID-19/complications , Dyspnea/drug therapy , Dyspnea/etiology , Fatigue , Glucosides , Humans , Sildenafil Citrate/therapeutic use

10.

Fluvoxamine for Acute COVID-19 Infection: Weak Hypothesis, Predictable Failure.

Manu, Peter.

Am J Ther ; 29(3): e342-e343, 2022.

Article in English | MEDLINE | ID: covidwho-1778984

Subject(s)

COVID-19 Drug Treatment , Fluvoxamine/therapeutic use , Humans , SARS-CoV-2 , Selective Serotonin Reuptake Inhibitors

11.

Expression of Concern for Bryant a, Lawrie TA, Dowswell T, Fordham EJ, Mitchell S, Hill SR, Tham TC. Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis to Inform Clinical Guidelines. Am J Ther. 2021;28(4): e434-e460.

Manu, Peter.

Am J Ther ; 29(2): e232, 2022 02 17.

Article in English | MEDLINE | ID: covidwho-1774442

12.

Expression of Concern for Kory P, Meduri GU, Varon J, Iglesias J, Marik PE. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021;28(3): e299-e318.

Manu, Peter.

Am J Ther ; 29(2): e231, 2022 02 14.

Article in English | MEDLINE | ID: covidwho-1774441

13.

Repurposing Drugs for Post-COVID-19 Fatigue Syndrome: Methylphenidate, Duloxetine, and Brexpiprazole.

Manu, Peter.

Am J Ther ; 29(2): e229-e230, 2022 01 03.

Article in English | MEDLINE | ID: covidwho-1752208

Subject(s)

COVID-19 , Methylphenidate , COVID-19/complications , Drug Repositioning , Duloxetine Hydrochloride/therapeutic use , Fatigue , Humans , Methylphenidate/therapeutic use , Quinolones , Thiophenes

14.

Post-COVID Fatigue: Functional Brain Imaging and Cognitive Testing.

Manu, Peter.

Am J Ther ; 29(1): e85-e86, 2021 12 01.

Article in English | MEDLINE | ID: covidwho-1612722

Subject(s)

COVID-19 , Brain/diagnostic imaging , Fatigue/etiology , Functional Neuroimaging , Humans , Neuropsychological Tests , SARS-CoV-2

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL